Yes. A growing clone's equity is designed to add value to your overall business and ultimately your valuation without diluting you until it makes financial sense to acquire your clone.
To be successful business needs proactive, funded, managed operations delivered by talented, trusted and motivated leadership - especially in B2B emerging markets businesses in today's faster global AI marketplace. Globiant delivers that better through cloning your company.
Yes. Globiant handles execution, capital raise, hiring, localization and more independently. It just needs your permission to do so.
Yes. Globiant sets-up quickly with launch staff for infra, funding, and recruiting founding teams.
Yes. Licensing and governance models protect your core IP and brand identity.
Yes. Governance and licensing agreements tie the clone’s success directly to your future vision, direction and execution.
Yes. Globiant drives raising investment locally, connects you into local ecosystems and builds native commercial GTM teams for higher chance of regional business success.
You retain structured rights to re-acquire, back consolidate the clone at the fair future value inflection - on your terms. This process deserves more of a conversation, so let's discuss your vision and interests.
Important are business growth, clients references, vision potential and some clone set-up investment and critically, leadership commitment! Profitability not required.
You decide the final terms and conditions of how the Clone relates to the US company and investors. You're the final decision maker!
Yes! Shows global fast growth ambition and strategic leverage without raising burn or complexity.
Copyright © 2025 Globiant - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.